GSK-3 BETA
9059-09-0
|
GSK-1
912953-25-4
|
GSK-239512
720691-69-0
|
GSK-J5
1394854-51-3
|
GSK-8573
1693766-04-9
|
GSK-J1
1373422-53-7
|
GSK 1702934A
924377-85-5
|
GSK 525768A
1260530-25-3
|
GSK-3β inhibitor 12
784170-07-6
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
2-Phenyl-1-(4-(pyrazin-2-yloxy)piperidin-1-yl)ethanone
1380824-59-8
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
N-(furan-3-ylmethyl)-N-(2-(thiophen-2-yl)ethyl)-4-(trifluoromethyl)benzamide
1421466-65-0
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
tert-Butyl-DL-alanine
1375289-11-4
|
